- Price is above the Trend Line, keeping the weekly tape constructive.
BP8
ASX
Week ended 24 Jul 2026
Weekly Investor Report
BPH Global Ltd · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
0.00 AUD
33.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 5.3% above the Trend Line and sits at 50.0% of its 52-week range. The latest completed week returned 33.3%, after a 33.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
43
out of 100
Latest Close
0.00 AUD
24 Jul 2026
1W Return
33.3%
latest completed week
4W Return
33.3%
short-term follow-through
12W Return
0.0%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 14.14% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
33.3%
Latest completed week; four-week move 33.3%.
Indicator stack
17/47
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 14.14%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
14 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 5.3% above the Trend Line and sits at 50.0% of its 52-week range. The latest completed week returned 33.3%, after a 33.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2812-week average 0.25
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.28Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 33.3% over four weeks, 0.0% over 12 weeks, and 0.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.29Latest activity-pressure read.
Pressure change34.7%Four-week change in activity pressure.
Leadership4.70Latest relative-leadership reading.
RS change121.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 30 Jun 2025
Field coverage 24%
Model confidence 13%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength94/100Blend of value, momentum, and quality. Underlying universe rank 7; rank 1 is best.
Value82/100Relative valuation strength. Underlying universe rank 19; rank 1 is best.
Quality81/100Profitability and accounting quality. Underlying universe rank 20; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 0/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- - Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 14 relevant articles.
1 positive · 12 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-33.3%Distance below the 52-week high.
13-week volatility23.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher5 of 265 weeks finished lower.
Best week+50.0%Week of 6 Feb.
Worst week-33.3%Week of 13 Feb.
Latest week+33.3%Week of 24 Jul.
Shape of recent returns
Strong gains5
Modest gains0
Flat weeks16
Modest losses0
Sharp losses5
Recent vol23.0%13-week weekly-return volatility.
Base vol22.5%52-week weekly-return volatility.
Up/down split8/8Count of positive and negative weeks in the 52-week window.
Average skew43.8% / -29.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank- / 100
Group average1.9%
Trend breadth22.0%
Trend22.0%active weekly trend signals
MD60.0%positive activity pressure
RS29.0%positive relative leadership
Four-week leaders
IndustryAU Drug Manufacturers - Specialty & Generic
4-week rank4 / 16
Group average16.0%
Trend breadth12.5%
Trend12.5%active weekly trend signals
MD62.5%positive activity pressure
RS25.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis25/100Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 6/12.
Activity pressure 0.28; No reversal markers Next-Week ExpectancyNegative 14.14%Next-week expectancy is negative with a 14.14% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors84/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 15 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 14 relevant articles.
BPH Global Limited Revenue Breakdown – ASX:BP8 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 0.00 AUD | 33.3% | 0.00 AUD | 0.00 AUD | -0.29 | 4.70 | 2.8M | Off |
| 17 Jul 2026 | 0.00 AUD | 0.0% | 0.00 AUD | 0.00 AUD | -0.52 | -21.71 | 0 | Off |
| 10 Jul 2026 | 0.00 AUD | -25.0% | 0.00 AUD | 0.00 AUD | -0.33 | -22.19 | 8.0M | Off |
| 3 Jul 2026 | 0.00 AUD | 33.3% | 0.00 AUD | 0.00 AUD | -0.41 | 2.73 | 3.6M | Off |
| 26 Jun 2026 | 0.00 AUD | -25.0% | 0.00 AUD | 0.00 AUD | -0.45 | -22.29 | 4.6M | Off |
| 19 Jun 2026 | 0.00 AUD | 33.3% | 0.00 AUD | 0.00 AUD | -0.30 | 2.29 | 0 | Off |
| 12 Jun 2026 | 0.00 AUD | -25.0% | 0.00 AUD | 0.00 AUD | -0.56 | -23.13 | 2.8M | Off |
| 5 Jun 2026 | 0.00 AUD | 0.0% | 0.00 AUD | 0.00 AUD | -0.55 | 4.05 | 590.8K | Off |
| 29 May 2026 | 0.00 AUD | 33.3% | 0.00 AUD | 0.00 AUD | -0.62 | 3.28 | 0 | Off |
| 22 May 2026 | 0.00 AUD | 0.0% | 0.00 AUD | 0.00 AUD | -0.65 | -22.33 | 11.0M | Off |
| 15 May 2026 | 0.00 AUD | -25.0% | 0.00 AUD | 0.00 AUD | -0.33 | -22.53 | 24.1M | Off |
| 8 May 2026 | 0.00 AUD | 0.0% | 0.00 AUD | 0.00 AUD | -0.01 | 1.37 | 10.9K | On |
| 1 May 2026 | 0.00 AUD | 0.0% | 0.00 AUD | 0.00 AUD | 0.08 | 0.38 | 1.4M | On |
| 24 Apr 2026 | 0.00 AUD | 0.0% | 0.00 AUD | 0.00 AUD | 0.19 | -0.38 | 905.7K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.